Table 1. Summary of meta-analysis and systematic reviews on PVE.
| Author, year | Type | # included studies/patients | Morbidity/mortality of PVE (%) | FLR increase (%) | Rates of successful resection (%) | Morbidity/mortality post-resection (%) | Difference between ipsilateral/contralateral transhepatic approach |
Difference between the choice of embolic |
|---|---|---|---|---|---|---|---|---|
| Abulkhir et al., 2008 (59) | Meta-analysis | 37/1,088 | 2.2/0 | 8-27 (DH) | 85 | 16/1.7 | None | None |
| Wajswol et al., 2018 (60) | Meta-analysis and Systematic Review | 18/607 | 3.1/not reported | 49.4 (RH) | 75.9 | 23.2/1.2 | None | None |
| Isofordink et al., 2017 (61) | Meta-analysis and Systematic Review | 17/1,953 | 3.9/not reported | 43.2 (RH) | Not reported | Not reported/3.8 | Not reported | Not reported |
| van Lienden et al., 2013 (62) | Meta-analysis and Systematic Review | 44/1,791 | 2.5/0.1 | 37.9 (RH) | 80 | 10.4/3.3 | Not reported | NBCA with greater FLR increase than gelfoam, PVA and fibrin glue |
PVE, portal vein embolization; FLR, future liver remnant; DH, degree of hypertrophy; RH, relative hypertrophy; NBCA, N-butyl cyanoacrylate; PVA, polyvinyl alcohol.